Michael K. Wirth - 02 Mar 2026 Form 4 Insider Report for CHEVRON CORP (CVX)

Role
Chairman and CEO, Director
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for Michael K. Wirth
Issuer symbol
CVX
Transactions as of
02 Mar 2026
Net transactions value
-$51,622,487
Form type
4
Filing time
04 Mar 2026, 18:09:48 UTC
Previous filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wirth Michael K Chairman and CEO, Director 1400 SMITH STREET, HOUSTON /s/ Rose Z. Pierson, Attorney-in-Fact for Michael K. Wirth 04 Mar 2026 0001354590

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise +182,100 +582% $125.35* 213,366 02 Mar 2026 Direct F1
transaction CVX Common Stock Sale $5,202,491 -27,672 -13% $188.01 185,694 02 Mar 2026 Direct F1, F2
transaction CVX Common Stock Sale $16,300,642 -86,329 -46% $188.82 99,365 02 Mar 2026 Direct F1, F3
transaction CVX Common Stock Sale $12,210,836 -64,399 -65% $189.61 34,966 02 Mar 2026 Direct F1, F4
transaction CVX Common Stock Sale $705,220 -3,700 -11% $190.60 31,266 02 Mar 2026 Direct F1
transaction CVX Common Stock Options Exercise +90,524 +290% $113.01* 121,790 02 Mar 2026 Direct
transaction CVX Common Stock Sale $17,203,299 -90,524 -74% $190.04 31,266 02 Mar 2026 Direct F5
holding CVX Common Stock 17,784 02 Mar 2026 By Limited Partnership F6
holding CVX Common Stock 18,684 02 Mar 2026 By 401(k) plan
holding CVX Common Stock 51 02 Mar 2026 By Wirth Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise -182,100 -100% $0.000000* 0 02 Mar 2026 Common Stock 182,100 $125.35 Direct F7
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise -90,524 -38% $0.000000* 146,376 02 Mar 2026 Common Stock 90,524 $113.01 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.
F2 These shares were sold in multiple transactions at prices ranging from $187.31 to $188.30, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
F3 These shares were sold in multiple transactions at prices ranging from $188.31 to $189.30, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F4 These shares were sold in multiple transactions at prices ranging from $189.31 to $190.12, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F5 These shares were sold in multiple transactions at prices ranging from $190.00 to $190.635, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F6 The reporting person owns only a 1% general partnership interest in the limited partnership. The remaining limited partnership interests are owned equally by four separate trusts for the benefit of each of the reporting person's children. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except to the extent of his pecuniary interest therein.
F7 Option granted 1/31/2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively.
F8 Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.